- Home
- SHOT vs RLYB Comparison
SHOT vs RLYB Comparison
Compare SHOT & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHOT
- RLYB
- Stock Information
- Founded
- SHOT 2018
- RLYB 2018
- Country
- SHOT United States
- RLYB United States
- Employees
- SHOT N/A
- RLYB N/A
- Industry
- SHOT Biotechnology: Pharmaceutical Preparations
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- SHOT Health Care
- RLYB Health Care
- Exchange
- SHOT Nasdaq
- RLYB Nasdaq
- Market Cap
- SHOT 30.4M
- RLYB 14.4M
- IPO Year
- SHOT 2020
- RLYB 2021
- Fundamental
- Price
- SHOT $0.43
- RLYB $0.41
- Analyst Decision
- SHOT
- RLYB Hold
- Analyst Count
- SHOT 0
- RLYB 3
- Target Price
- SHOT N/A
- RLYB $15.00
- AVG Volume (30 Days)
- SHOT 6.3M
- RLYB 8.1M
- Earning Date
- SHOT 08-13-2025
- RLYB 08-07-2025
- Dividend Yield
- SHOT N/A
- RLYB N/A
- EPS Growth
- SHOT N/A
- RLYB N/A
- EPS
- SHOT N/A
- RLYB N/A
- Revenue
- SHOT $573,336.00
- RLYB $848,000.00
- Revenue This Year
- SHOT N/A
- RLYB N/A
- Revenue Next Year
- SHOT N/A
- RLYB N/A
- P/E Ratio
- SHOT N/A
- RLYB N/A
- Revenue Growth
- SHOT 69.32
- RLYB N/A
- 52 Week Low
- SHOT $0.23
- RLYB $0.22
- 52 Week High
- SHOT $1.77
- RLYB $1.54
- Technical
- Relative Strength Index (RSI)
- SHOT 54.76
- RLYB 55.26
- Support Level
- SHOT $0.35
- RLYB $0.32
- Resistance Level
- SHOT $0.48
- RLYB $0.61
- Average True Range (ATR)
- SHOT 0.06
- RLYB 0.05
- MACD
- SHOT 0.01
- RLYB 0.01
- Stochastic Oscillator
- SHOT 46.94
- RLYB 34.82
About SHOT Safety Shot Inc.
Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.